SKIN
A development-stage X-series program designed to coordinate selected anti-inflammatory, regenerative and dermal-epidermal signaling pathways for advanced skin research and formulation co-development.
Quick Facts
- Development-Stage Engineered EV Program
- Program Status: Development stage
- Specification: Coming soon
- Target Presentation: Refrigerated
- Research Focus: Precision skin regeneration
- Collaboration: Co-development
- Development Stage
- X-SKIN
- Co-development
- Skin Models
A development-stage engineered-EV program distinct from the mature native NCSK material.
SKIN is positioned separately from GoldenExo® NCSK. NCSK is a mature native MSC-EV formulation platform; SKIN is a development-stage engineered EV program intended for projects that require selected pathway enhancement and deeper mechanistic customization.
Inflammatory-Pathway Engineering: Explore enhanced delivery of selected signals intended to regulate disruptive skin-microenvironment responses.
Regenerative Signaling: Develop cargo strategies focused on fibroblast, keratinocyte and basal-cell repair pathways.
Structural-Remodeling Research: Study dermal-epidermal communication and extracellular-matrix related endpoints.
Modular Co-Development: Supports project-specific cargo, formulation, quality and application-model design.
Co-development flow from construct strategy to application model
01 Target & Cargo Strategy: Confirm target pathway, cargo direction and research model.
02 Producer-Cell Development: Evaluate engineered producer-cell construction and loading strategy.
03 EV Manufacturing & Purification: Build a reproducible engineered-EV preparation workflow.
04 Loading & Identity Testing: Evaluate EV identity, loading, purity and integrity.
05 Formulation & Delivery: Explore local delivery, dose window and application format.
06 Function & Scale-Up: Connect model validation, batch consistency and further-manufacturing evaluation.
From Cargo Enhancement to Skin-Model Endpoint Evaluation
Engineered Construct Confirmation: Engineered cargo or construct strategy confirmation; Producer-cell and loading-direction evaluation; Project-level construct records and change control
EV Identity & Loading Evaluation: EV particle identity, concentration and purity; Loading-positive rate or cargo characterization; Membrane integrity and batch consistency
Functional Model Validation: Cell models selected around target pathways; Activity, stability and formulation-compatibility support; Application models expanded by collaboration scope
Co-Development Documentation: Development-stage technical package; Analytical methods and batch-result records; Connection to OEM, ODM or CDMO collaboration
Product-specific analytical focus: The development package may include cargo identity, loading-positive rate, EV identity and purity, cellular activity, formulation compatibility, stability and relevant skin-model endpoints.
Where the Product Can Fit
Microenvironment Regulation: Research selected anti-inflammatory and homeostasis-related engineering strategies.
Cellular Regeneration: Evaluate responses in fibroblast, keratinocyte and relevant skin-model systems.
Matrix and Barrier Research: Explore collagen, extracellular matrix, barrier and hydration-related endpoints.
Local-Delivery Development: Assess compatible professional application formats and stability requirements.
Key Information for Technical Evaluation
Program Name: SKIN / X-SKIN
Program Type: Engineered exosome co-development program
Program Status: Development stage
Specification: Coming soon
Target Presentation: Refrigerated
Research Focus: Precision skin regeneration, microenvironment regulation and local-delivery development
Collaboration: Cargo strategy, producer cell, formulation, dose, analytical package and application model
The current public page communicates the platform rationale rather than a finalized product composition. Project-specific details are discussed under an appropriate collaboration framework.
From Concept Validation to Engineering Collaboration
Target & Cargo Co-Development: Evaluate target pathways, cargo selection and construct strategy.
Producer Cell & Process: Support producer-cell development, EV preparation and purification optimization.
Function & Application Models: Design functional models, dose and delivery route by research scenario.
Further Manufacturing Path: Mature programs can connect to OEM, ODM or CDMO collaboration.
FAQ
- Is SKIN the same product as GoldenExo® NCSK?
- No. NCSK is a mature native MSC-EV formulation material. SKIN is a development-stage engineered EV program designed for selected cargo and pathway enhancement.
- Is the final cargo composition publicly disclosed?
- The current public page communicates the platform rationale rather than a finalized product composition. Project-specific details are discussed under an appropriate collaboration framework.
- Can the program be customized for a specific application model?
- Yes. Cargo strategy, producer cell, formulation, dose, analytical package and application model can be evaluated through co-development.
- Is SKIN an approved medical or cosmetic treatment?
- No. It is a development-stage research and further-manufacturing program and is not represented as an approved finished treatment.